Education
About Us
Working with TipRanks
Follow Us
9 Meters Biopharma (NMTRQ)
OTHER OTC:NMTRQ
| Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | - | - | - | - | - |
| Operating Income | $ -42.02M | $ -36.76M | $ -60.88M | $ -25.58M | $ -18.22M |
| EBITDA | $ -39.30M | $ -36.72M | $ -57.43M | $ -24.21M | $ -15.48M |
| Net Income | $ -43.77M | $ -36.78M | $ -61.50M | $ -27.13M | $ -24.16M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 33.10M | $ 50.17M | $ 39.16M | $ 5.30M | $ 6.45M |
| Total Debt | $ 19.73M | $ 167.94K | $ 230.78K | $ 3.23M | $ 5.20M |
| Net Debt | $ 7.13M | $ -46.83M | $ -37.70M | $ -1.44M | $ -607.23K |
| Total Liabilities | $ 30.75M | $ 8.57M | $ 7.02M | $ 14.91M | $ 10.11M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -37.25M | $ -29.49M | $ -19.41M | $ -17.90M | $ -15.18M |
| Operating Cash Flow | $ -37.24M | $ -29.48M | $ -19.41M | $ -17.89M | $ -15.17M |
| Investing Cash Flow | |||||
| Financing Cash Flow |
9 Meters Biopharma Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.